Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy

Tundra lists 1 Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT07695207

Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy

The purpose of this study is to evaluate the efficacy and safety of SMZ1 tablets in combination with Ranibizumab compared with placebo in combination with Ranibizumab in subjects with neovascular (wet) age-related macular degeneration (nAMD) without polypoidal choroidal vasculopathy (PCV). The primary objective is to demonstrate the superiority of SMZ1 tablets over placebo with respect to improvement in best-corrected visual acuity at Month 12.

Gender: All

Ages: 50 Years - Any

Updated: 2026-07-10

1 state

Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy